FINANCIAL REVIEW
Sarah Thompson andAnthony MacdonaldJun 3, 2019 — 10.12am
Shares in ASX-listed LBT Innovations are in a trading halt while the company raises fresh funds to accelerate its sales and marketing efforts.LBT Innovations and its broker Hawkesbury Partners were pitching the story to fund managers on Monday morning, seeking to raise $4 million to $5 million in a placement of new shares.Shares were being offered at 14.5¢ each, which was a discount to the last close of 17¢.Funds raised were pegged for working capital and sales and marketing. The raising was expected to close on Monday afternoon.It comes soon after LBT Innovations received FDA approval for its APAS Independence testing system, which is an automated pathology testing product.
Ann: Trading Halt, page-18
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $21.75M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.4¢ | $27.28K | 1.812M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1064357 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 894780 | 2 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| LBT (ASX) Chart |